Kaken Pharmaceutical Co (TSE:4521) Other Long Term Assets : 円25,972 Mil (As of Dec. 2023)

View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Other Long Term Assets?

Kaken Pharmaceutical Co's other long-term assets for the quarter that ended in Dec. 2023 was 円25,972 Mil.

Kaken Pharmaceutical Co's quarterly other long-term assets increased from Jun. 2023 (円26,012 Mil) to Sep. 2023 (円26,389 Mil) but then stayed the same from Sep. 2023 (円26,389 Mil) to Dec. 2023 (円25,972 Mil).

Kaken Pharmaceutical Co's annual other long-term assets declined from Mar. 2021 (円24,025 Mil) to Mar. 2022 (円20,598 Mil) but then increased from Mar. 2022 (円20,598 Mil) to Mar. 2023 (円24,186 Mil).

Kaken Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for Kaken Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Other Long Term Assets Chart

Kaken Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long Term Assets

Get a 7-Day Free Trial

25,301.00

23,607.00

24,025.00

20,598.00

24,186.00

Kaken Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															20,858.00	24,186.00	26,012.00	26,389.00	25,972.00

Kaken Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Kaken Pharmaceutical Co (TSE:4521) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

KKPCF:USA

Address

28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650

Website

http://www.kaken.co.jp

Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co (TSE:4521) Headlines

No Headlines